Momelotinib

CAS 1056634-68-4

Overview

Momelotinib is used to treat certain types of myelofibrosis (a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production) in adults who have anemia

Anant Labs manufacture and furnish high quality Momelotinib impurities for global markets. Our Momelotinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Momelotinib

CAS 1056634-68-4In Stock

Technical Data

CAS1056634-68-4

Mol. FormulaC₂₃H₂₂N₆O₂

Mol. Weight414.469 g/mol

IUPACN-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide

SMILESC1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)NCC#N

InChIInChI=1S/C23H22N6O2/c24-10-12-25-22(30)18-3-1-17(2-4-18)21-9-11-26-23(28-21)27-19-5-7-20(8-6-19)29-13-15-31-16-14-29/h1-9,11H,12-16H2,(H,25,30)(H,26,27,28)

InChI KeyZVHNDZWQTBEVRY-UHFFFAOYSA-N

Note: We are upgrading our system, Cat No will change.

Synonyms

MOMELOTINIB1056634-68-4Cyt387Cyt-387N-(Cyanomethyl)-4-(2-((4-morpholinophenyl)amino)pyrimidin-4-yl)benzamideN-(cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]benzamideCYT-11387momelotinibumGS-03876O01GMS00P